»

DrugPatentWatch

DrugPatentWatch concentrates deep knowledge on more than 6,400 small-molecule drugs and 2,300 generic ingredients from 1,700 branded and generic pharmaceutical companies and 700 suppliers, and more than 4,400 active and expired US patents and 74,000 international patents spanning 93 countries and regional patent offices.

Generic Name: amlodipine besylate; atorvastatin calcium

Summary for Generic Name: amlodipine besylate; atorvastatin calcium

Tradenames:1
Patents:4
Applicants:1
NDAs:1
Drug Master File Entries: see list41
Suppliers: see list4

Pharmacology for Ingredient: amlodipine besylate; atorvastatin calcium

Clinical Trials for: amlodipine besylate; atorvastatin calcium

A Multi-Risk Factor Strategy vs a Guideline-Based Approach in Achieving Blood Pressure and Lipid Goals in Hypertensives at Extra Risk
Status: Completed Condition: Dyslipidemia; Hypertension

Amlodipine/Atorvastatin (Caduet®) Drug Use Investigation (Regulatory Post Marketing Commitment Plan)
Status: Completed Condition: Hypertension; Angina Pectoris; Hypercholesterolemia; Familial Hypercholesterolemia

Study to Investigate the Effect of Atorvastatin on the Pharmacokinetic Properties of Telmisartan/S-amlodipine
Status: Recruiting Condition: Essential Hypertension; Hyperlipidemia

Comparing Amlodipine/Atorvastatin Co-Administration To Amlodipine Alone In Patients With Hypertension And Dyslipidemia
Status: Completed Condition: Hypertension; Hyperlipidemia

Study to Investigate the Effect of Telmisartan/S-amlodipine on the Pharmacokinetic Properties of Atorvastatin.
Status: Not yet recruiting Condition: Essential Hypertension; Hyperlipidemia

Open Label Study To Assess The Effectiveness Of Amlodipine-Atorvastatin Combination In Hypertension And Dyslipidemia.
Status: Completed Condition: Hypertension; Hyperlipidemia

Double Blind Atorvastatin Amlodipine Study
Status: Completed Condition: Angina

Amlodipine/Atorvastatin Combination to Reduce the Health Risk of High Blood Pressure and High Cholesterol Levels
Status: Completed Condition: Hypertension; Hyperlipidemia

A Randomized Study To Evaluate Efficacy And Safety Of A Fixed Combination Therapy Of Amlodipine And Atorvastatin
Status: Completed Condition: Hypertension; Hypercholesterolemia

Open Label Study Assessing Effectiveness Of Amlodipine/Atorvastatin In Subjects With Hypertension and Dyslipidaemia
Status: Completed Condition: Hypertension; Dyslipidemia

Courtesy of ClinicalTrials.org
See more clinical trials for this drug

Litigation for: AMLODIPINE

Litigation for: ATORVASTATIN


Glossary
Applicant Tradename Generic Name Dosage NDA Approval Date Type RLD Patent No. Product Substance Delist_Flag Patent Expiration Patented / Exclusive Use
Pfizer
CADUET
amlodipine besylate; atorvastatin calcium
TABLET; ORAL021540Jan 30, 2004RXNo5,686,104*PEDY<disabled>
Pfizer
CADUET
amlodipine besylate; atorvastatin calcium
TABLET; ORAL021540Jan 30, 2004RXNo5,969,156*PEDY<disabled>
Pfizer
CADUET
amlodipine besylate; atorvastatin calcium
TABLET; ORAL021540Jan 30, 2004RXNo6,126,971*PEDY<disabled>
Pfizer
CADUET
amlodipine besylate; atorvastatin calcium
TABLET; ORAL021540Jan 30, 2004RXNo6,455,574<disabled>TREATMENT OF HYPERTENSION AND HYPERLIPIDEMIA WITH A SINGLE COMPOSITION
The preview shows a limited data set. Complete access is available with a Subscription
first patents previous patents next patents last patents

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

DrugPatentWatch Archives

You are viewing the current data set
Select a link below to view the archives:

 2000  2001  2002  2003  2004  2005  2006  2007  2008  2009 
 2010  2011 

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors.

Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided information. There is no warranty that the information contained herein is error free. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Sign up for a free trial

No commitment, no credit card required
First name
Last name
Email address

Connect with Social Media:

Follow DrugPatentWatch on Twitter Connect with DrugPatentWatch on Linkedin Drug Patents on LinkedIn

Copyright © 2002-2013 thinkBiotech LLC. ISSN: 2162-2639


`abc